Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

May 13, 2016

Severe Rebound Effects Found in ‘Relevant’ Number of MS Patients After Stopping Fingolimod

  • MS Drug Therapies
    /
  • Multiple Sclerosis (MS) Symptoms
    /
                                       …
MS Drug Therapies

May 13, 2016

Stem Cell Therapy: Modern Medicine’s Promising Future For MS Treatment

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
                                       …
Multiple Sclerosis

May 12, 2016

Slideshow: A Visual Guide to Understanding Stroke

  • Misc. Tips - Non MS Related
    /
                                       …
Misc. Tips - Non MS Related

May 12, 2016

A New Comprehensive MS learning program taking place by Columbus, Ohio in mid June

  • MS Educational Programs
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
                                       …
MS Educational Programs

May 12, 2016

Opexa’s CEO Gives Update on T-Cell Therapy for NMO, MS and other autoimmune disorders

  • MS Research Study and Reports
    /
                                       …
MS Research Study and Reports

May 10, 2016

High Glutamate Levels in Brain Seen to Drive MS Progression

  • MS Research Study and Reports
    /
                                       …
MS Research Study and Reports

May 7, 2016

Yoga and Aquatic Exercise Seen to Markedly Ease MS-related Depression and Fatigue

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
                                       …
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

May 5, 2016

New News for Acthar Gel (aka: ACTH ) – an Effective Treatment for MS Relapses

  • Marketing
    /
                                       …
Marketing

May 5, 2016

Zinbryta (daclizumab HYP) is favored for approval in Europe

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
                                       …
MS Drug Therapies

May 3, 2016

European Program Aims to Develop Wearable Devices to Monitor and Treat MS

  • MS Research Study and Reports
    /
                                       …
MS Research Study and Reports

Categories

Latest Blog Posts